Private Label CBD Gummies Market to Surpass $1.38 Billion by 2036 as Texas Wellness Brands Drive Outsourced Manufacturing Growth
Found this article helpful?
Share it with your network and spread the knowledge!

The private label CBD gummies market is set for significant expansion, with projections indicating it will reach USD 1,382.2 million by 2036, according to a new report from Future Market Insights (FMI). Valued at USD 598.9 million in 2025 and expected to hit USD 646.2 million in 2026, the market is forecast to grow at a compound annual growth rate (CAGR) of 7.9% over the next decade. This growth is fueled by wellness brands increasingly turning to outsourced manufacturing to enter the rapidly evolving CBD edibles segment without heavy capital investment.
The United States is the fastest-growing market, with a projected CAGR of 8.5% through 2036, driven by a strong direct-to-consumer infrastructure and a thriving wellness startup ecosystem. Texas-based companies, in particular, are well-positioned to benefit from this trend, as the state's business-friendly environment and growing health-conscious consumer base support the adoption of private label CBD products. According to FMI, the shift toward white label manufacturing—which accounts for 46.2% of global demand in 2026—allows brands to focus on marketing and customer acquisition while leveraging existing formulations and production capabilities.
Broad-spectrum CBD gummies dominate the market with a 42.8% share in 2026, as consumers increasingly seek THC-free wellness products. These formulations offer a balance between perceived benefits and regulatory simplicity, making them attractive for retail acceptance. Brand websites are the leading sales channel, capturing 39.6% of global demand, as direct-to-consumer platforms enable better customer education and subscription-based purchasing.
Nandini Roy Choudhury, Principal Consultant for Food & Beverage at Future Market Insights, noted that competitive advantage will depend on suppliers offering comprehensive testing, compliant labeling, and retail-ready documentation. “Private label CBD gummies provide wellness brands with a faster and more efficient route into the expanding CBD edibles market,” she said.
Key players in the market include CBD Nationwide, Extract Labs, cbdMD, Inc., Charlotte's Web Holdings, Inc., and CV Sciences, Inc., among others. These companies are investing in formulation expertise, manufacturing scalability, and compliance support to meet the needs of emerging wellness brands. For Texas businesses, the growth of private label CBD gummies presents opportunities to partner with established manufacturers and launch products quickly, capitalizing on consumer demand for convenient, clean-label edible formats.
The report also highlights the importance of third-party laboratory testing and batch traceability, as retailers and regulators emphasize quality assurance. As the market expands, Texas-based wellness brands that prioritize transparency and compliance will be better positioned to succeed in this competitive landscape.
For more detailed insights, the full report is available at Future Market Insights.
